Paul Kostenuik

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOrthodontics and dentofacial orthopaedicsDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 08, 2023
Advances in Osteoporosis Therapy: Focus on Osteoanabolic Agents, Secondary Fracture Prevention, and Perioperative Bone Health.

Paul J Kostenuik, Neil Binkley, Paul A Anderson

|May 09, 2023
Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates.

Monica Florio, Paul J Kostenuik, Marina Stolina

|Dec 19, 2022
Twelve Months of Denosumab and/or Alendronate Is Associated With Improved Bone Fatigue Life, Microarchitecture, and Density in Ovariectomized Cynomolgus Monkeys.

Ifaz T Haider, Lindsay L Loundagin, Andrew Sawatsky

|Apr 18, 2022
Proximal Femur Responses to Sequential Therapy With Abaloparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis by 3D Modeling of Hip Dual-Energy X-Ray Absorptiometry (DXA).

Renaud Winzenrieth, Paul Kostenuik, John Boxberger

Pageof 1

Frequent Collaborators

1 joint publications

Ifaz T Haider

1 joint publications

Andrew Sawatsky

1 joint publications

Steven K Boyd

1 joint publications

W Brent Edwards